Showing results (11-20 of 39) with videos related to
Sort By:
Pageof 4
The Journal of Biological Chemistry|November 5, 2003
Hypoxia potentiates nitric oxide-mediated apoptosis in endothelial cells via peroxynitrite-induced activation of mitochondria-dependent and -independent pathwaysGeoffrey A Walford, Rose-Laure Moussignac, Anne W Scribner, et al.The Journal of Comparative Neurology|December 18, 2001
Defining classes of spinal interneuron and their axonal projections in hatchling Xenopus laevis tadpolesW C Li, R Perrins, S R Soffe, et al.Journal of Diabetes Science and Technology|September 5, 2017
Rate of Change of Premeal Glucose Measured by Continuous Glucose Monitoring Predicts Postmeal Glycemic Excursions in Patients With Type 1 Diabetes: Implications for TherapyAmit R Majithia, Alexander B Wiltschko, Hui Zheng, et al.Clinical and Translational Science|January 24, 2024
Pooled analysis of routine safety parameters observed in healthy participants at baseline and following placebo administration in early phase clinical studiesKelly E Duncan, Runcheng Li, Lata Maganti, et al.Diabetes, Obesity & Metabolism|July 13, 2019
A 96-week, multinational, randomized, double-blind, parallel-group, clinical trial evaluating the safety and effectiveness of bexagliflozin as a monotherapy for adults with type 2 diabetesYuan-Di C Halvorsen, Geoffrey A Walford, Joseph Massaro, et al.Plos One|March 17, 2011
Transcriptome analysis of the vernalization response in barley (Hordeum vulgare) seedlingsAaron G Greenup, Sharyar Sasani, Sandra N Oliver, et al.Food & Nutrition Research|January 20, 2016
A pilot, short-term dietary manipulation of branched chain amino acids has modest influence on fasting levels of branched chain amino acidsNicole Landa Cavallaro, Jamie Garry, Xu Shi, et al.Diabetes|February 11, 2016
Metabolite Profiles of Diabetes Incidence and Intervention Response in the Diabetes Prevention ProgramGeoffrey A Walford, Yong Ma, Clary Clish, et al.Clinical Pharmacology and Therapeutics|April 7, 2022
A Randomized, Single Ascending Dose Study to Assess the Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of a Novel Insulin DimerGeoffrey A Walford, Kelly E Duncan, Moises Hernandez, et al.Clinical Pharmacology and Therapeutics|June 13, 2023
Considerations for Cell and Gene Therapy Programs Entering the Clinical SpaceGeoffrey A Walford, An Bautmans, Carol Cannon, et al.Pageof 4